Your browser is no longer supported. Please, upgrade your browser.
STRO Sutro Biopharma, Inc. monthly Stock Chart
STRO [NASD]
Sutro Biopharma, Inc.
Index- P/E- EPS (ttm)-0.09 Insider Own0.70% Shs Outstand36.89M Perf Week-8.33%
Market Cap632.28M Forward P/E- EPS next Y-2.74 Insider Trans-84.12% Shs Float33.71M Perf Month30.23%
Income12.60M PEG- EPS next Q-0.59 Inst Own98.20% Short Float7.84% Perf Quarter79.93%
Sales45.70M P/S13.84 EPS this Y-57.10% Inst Trans27.79% Short Ratio7.00 Perf Half Y64.84%
Book/sh6.62 P/B2.49 EPS next Y-4014.30% ROA5.60% Target Price21.00 Perf Year55.81%
Cash/sh7.34 P/C2.25 EPS next 5Y- ROE8.00% 52W Range6.00 - 19.18 Perf YTD50.00%
Dividend- P/FCF- EPS past 5Y- ROI-51.50% 52W High-14.00% Beta-
Dividend %- Quick Ratio9.80 Sales past 5Y- Gross Margin- 52W Low175.00% ATR1.13
Employees182 Current Ratio9.80 Sales Q/Q44.70% Oper. Margin- RSI (14)57.84 Volatility7.74% 7.69%
OptionableYes Debt/Eq0.10 EPS Q/Q180.40% Profit Margin27.60% Rel Volume0.89 Prev Close17.03
ShortableYes LT Debt/Eq0.10 Earnings- Payout- Avg Volume377.58K Price16.50
Recom1.70 SMA204.45% SMA5025.75% SMA20058.99% Volume336,713 Change-3.11%
Sep-02-20Initiated Jefferies Buy $21
Jul-16-20Initiated Wells Fargo Overweight $18
Jan-13-20Initiated SunTrust Buy $18
Oct-07-19Initiated BTIG Research Buy $19
Jul-18-19Initiated Deutsche Bank Buy $22
Apr-29-19Initiated H.C. Wainwright Buy $18
Oct-22-18Initiated Wedbush Outperform $20
Oct-22-18Initiated Piper Jaffray Overweight $23
Oct-22-18Initiated JMP Securities Mkt Outperform $28
Nov-24-20 07:00AM  
Nov-18-20 07:00AM  
Nov-09-20 09:49AM  
Nov-05-20 07:00AM  
Nov-03-20 01:33PM  
Oct-12-20 12:10PM  
Sep-21-20 07:00AM  
Sep-10-20 07:20AM  
Sep-09-20 04:01PM  
Sep-04-20 07:27AM  
Sep-03-20 04:27PM  
07:55AM  
07:00AM  
Sep-02-20 04:12PM  
10:22AM  
Aug-25-20 07:00AM  
Aug-11-20 07:00AM  
Aug-10-20 05:00PM  
Aug-06-20 12:15PM  
07:00AM  
Aug-05-20 12:30PM  
Jun-30-20 11:06PM  
Jun-22-20 07:00AM  
Jun-11-20 02:34PM  
Jun-09-20 07:00AM  
Jun-08-20 06:06PM  
01:25PM  
Jun-03-20 04:49PM  
May-27-20 08:46AM  
May-25-20 03:20PM  
May-21-20 07:15AM  
07:00AM  
May-14-20 04:01PM  
May-13-20 11:25AM  
May-12-20 04:45PM  
May-11-20 11:55PM  
04:15PM  
Apr-27-20 12:01AM  
Apr-20-20 04:35PM  
Apr-13-20 05:00PM  
11:01AM  
Mar-26-20 09:20AM  
07:00AM  
Mar-16-20 08:35AM  
07:00AM  
Mar-12-20 07:00AM  
Mar-04-20 07:00AM  
Feb-06-20 01:13PM  
Feb-05-20 07:30AM  
Jan-09-20 07:00AM  
Jan-08-20 09:26AM  
Dec-19-19 04:46PM  
Nov-19-19 07:00AM  
Nov-08-19 10:57AM  
07:00AM  
Oct-30-19 01:59PM  
Oct-29-19 07:32AM  
07:00AM  
Oct-27-19 12:56PM  
Oct-16-19 04:35PM  
Oct-08-19 07:00AM  
Sep-04-19 07:00AM  
Sep-03-19 10:32AM  
Aug-14-19 06:15AM  
Aug-08-19 07:00AM  
Jul-31-19 12:52PM  
Jul-04-19 04:08PM  
Jun-24-19 04:05PM  
Jun-18-19 07:00AM  
Jun-15-19 06:00AM  
May-16-19 09:02AM  
May-15-19 07:00AM  
Apr-08-19 05:42PM  
Apr-04-19 07:00AM  
Apr-01-19 05:00AM  
Mar-15-19 07:00AM  
Mar-05-19 07:00AM  
Jan-29-19 07:00AM  
Jan-03-19 04:05PM  
Dec-20-18 01:08PM  
Dec-19-18 07:00AM  
Dec-05-18 10:35AM  
Nov-26-18 07:00AM  
Nov-14-18 05:33PM  
Nov-13-18 07:00AM  
Nov-08-18 07:00AM  
Oct-12-18 07:00AM  
Oct-01-18 01:34PM  
Sep-27-18 07:23AM  
Sep-26-18 06:58PM  
Sep-22-18 04:15PM  
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers. It has collaboration and license agreement with Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hallam TrevorChief Scientific OfficerNov 05Option Exercise4.3616,75173,03453,463Nov 06 05:08 PM
Hallam TrevorChief Scientific OfficerNov 05Sale15.0016,751251,26536,712Nov 06 05:08 PM
Hallam TrevorChief Scientific OfficerOct 05Option Exercise4.369,18240,03436,712Oct 06 04:54 PM
Hallam TrevorChief Scientific OfficerSep 28Sale10.2697510,00727,530Sep 28 05:55 PM
NEWELL WILLIAM JCEOSep 25Option Exercise0.0025,2520191,879Sep 28 05:57 PM
MOLINA ARTURO MDChief Medical OfficerSep 25Option Exercise0.008,609020,692Sep 28 05:56 PM
Hallam TrevorChief Scientific OfficerSep 25Option Exercise0.0017,906030,886Sep 28 05:55 PM
FITZPATRICK LINDA AChief People & Comm. OfficerSep 25Option Exercise0.007,576016,583Sep 28 05:54 PM
ALBINI EDWARD CCFO and SecretarySep 25Option Exercise0.007,174013,556Sep 28 05:52 PM
Shabbir AnikChief Technical Ops. OfficerSep 25Option Exercise0.008,609014,241Sep 28 05:53 PM
Freund John GordonDirectorSep 18Sale12.00400,0004,800,000560,053Sep 22 04:56 PM
Freund John GordonDirectorSep 11Sale10.00500,0005,000,000960,053Sep 15 05:15 PM
Hallam TrevorChief Scientific OfficerAug 26Sale9.049758,81816,790Aug 27 05:04 PM
Freund John GordonDirectorAug 19Sale8.72500,0004,360,0001,460,053Aug 21 05:18 PM
Hallam TrevorChief Science OfficerJul 27Sale8.069757,85817,765Jul 28 05:08 PM
Hallam TrevorChief Science OfficerMay 26Sale10.009759,75319,715May 27 06:38 PM
NEWELL WILLIAM JCEOMay 14Buy7.7564,516499,999166,627May 14 05:29 PM
MOLINA ARTURO MDChief Medical OfficerMay 14Buy7.756,45149,99512,083May 14 05:27 PM
FITZPATRICK LINDA AChief People & Comm. OfficerMay 14Buy7.753,22524,9949,007May 14 05:26 PM
Hallam TrevorChief Science OfficerApr 27Sale9.429759,18320,690Apr 27 08:24 PM
Hallam TrevorChief Science OfficerMar 26Sale9.699759,45321,665Mar 27 05:32 PM
Hallam TrevorChief Science OfficerFeb 26Sale10.4797510,20722,640Feb 27 05:34 PM
Hallam TrevorChief Science OfficerJan 27Sale10.5197510,25023,615Jan 28 04:48 PM
Hallam TrevorChief Science OfficerDec 26Sale11.0897510,80224,590Dec 27 05:31 PM
Hallam TrevorChief Science OfficerNov 26Sale10.6897510,41025,565Nov 27 04:50 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.